Capstone Partners advised Prince Sterilization Services—a leading provider of sterilization services and ready-to-use (RTU) drug containment solutions serving the pharmaceutical, biotechnology, compounding pharmacy, and medical device sectors—on its recapitalization transaction with Vance Street Capital.
With an exceptional technical team, state-of-the-art facilities and equipment, and innovative technology, Prince provides clients with a comprehensive array of eco-friendly sterilization and related services including steam, dry heat, vaporized hydrogen peroxide (VHP), depyrogenation, water for injection (WFI) rinsing, and sterile packaging. The company’s expert team works closely with clients to develop and validate sterilization services offering feasibility, engineering, analytical services, and routine processing cycle support. The company’s RTU division offers an extensive portfolio of pre-sterilized vials, seals, and stoppers that are 100% cleanroom processed, satisfying the strictest regulatory requirements for both the pharmaceutical and 503B compounding pharmacy markets. Prince also offers custom cleanroom packaging solutions designed to be compatible with the sterilization methods used for pharmaceutical and medical device products. The company is ISO 13485 certified, registered with the FDA, and is cGMP compliant. For more information visit princesterilization.com.
It was a pleasure working with the team at Capstone. Their strategic advice, support, and understanding of our company and the market were invaluable to us as we navigated this complex process. Looking forward, we are excited about our partnership with Vance Street Capital. The team at Vance Street has a proven track record of successfully investing in and growing businesses within the medical device sector. We remain committed to providing the highest quality services, products, and customer service to all our customers.
Prince Sterilization Services was founded by Dr. Daniel Prince (CEO). Dr. Derek Prince serves as the President. Both Daniel and Derek will retain a material ownership position and continue to run the business’s day-to-day operations.
Daniel Prince, Founder and CEO, Prince Sterilization Services, said “I am excited that we have executed our five-year plan with a win-win outcome. I am confident that in Vance Street Capital we have chosen an excellent partner to grow the business and lead the industry.”
“Dan, Derek, Jozef Mastej, and the rest of the Prince team have built a truly exceptional company, with a loyal client base and sterling reputation for quality, renowned for its unique capabilities and expertise in the field of sterilization. There is a strong cultural alignment between Vance Street and the Prince family, and with Vance Street’s support and resources to accelerate the team’s initiatives and expansion plans, I am confident that the partnership will result in continued growth and success for Prince Sterilization. It was a pleasure to work with Dan and Derek Prince once again, having previously advised the father and son team on the sale of Gibraltar Laboratories, an outsourced microbiology and analytical chemistry testing company serving the pharmaceutical and medical device sectors,“ commented Eric Williams, Managing Director of the Philadelphia-based Capstone deal team.
Vance Street Capital is a middle-market private equity firm focused on investing in highly engineered solutions businesses across the industrial technology, medical, life science, aerospace, and defense sectors. Vance Street works with management teams and family owners to accelerate revenue growth, improve operations, and acquire strategic assets for the companies in their investment portfolio. For more information visit vancestreetcapital.com.
“Prince Sterilization Services has grown at an impressive rate, a testament to the strength of market demand and the Company’s operational excellence, exemplary client service, and continued commitment to invest in adding capacity and new capabilities. The Company is uniquely positioned to further capitalize on high growth sectors benefiting from favorable dynamics – mounting public concern and regulatory oversight on drug and medical device safety and sterility, increasing demand for pre-sterilized primary containers suitable for aseptic fill and finish processes, rising proportion of FDA approvals and pharma pipeline are biologics, and increasing adoption of RTU as pharma seeks to reduce contamination risk and expedite production and clinical development timelines. We are excited to see what the future holds for the Prince family and Prince Sterilization Services,” remarked Mark Surowiak, Director at Capstone.
Capstone Partners has deep experience in the pharmaceutical and medical device outsourcing sector previously representing ToxStrategies, Gibraltar Laboratories, Concord Biosciences, MMi Sonora, EB Industries, and Whitehouse Analytical Laboratories.
The expert investment banking professionals on Capstone Partners’ Healthcare Team work with leading middle market companies operating in the healthcare services market to advise with their strategic decision-making in order to maximize financial outcomes at every stage of the business lifecycle. Our firm has developed a full suite of corporate finance solutions, including M&A advisory, debt advisory, financial advisory, and equity capital financing, to help privately owned businesses and private equity firms address any need, ranging from growth and financial or operational advisement to an ultimate exit transaction. To learn more about this transaction, or about the benefits of starting a relationship with our Healthcare Banking Team, contact us here.
